Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection FractionRobert J. Mentz, Christopher M. O’Connor, Bertram Pitt et al.|Journal of the American College of Cardiology|2014Cited by 541
Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical TrialsAyman Samman Tahhan, Javed Butler, Muthiah Vaduganathan et al.|JAMA Cardiology|2018Cited by 204
Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical TrialsJacob P. Kelly, Carolyn S.P. Lam, Robert J. Mentz et al.|Journal of the American College of Cardiology|2015Cited by 139
In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection FractionVishal N. Rao, Stephen J. Greene, Evan Murray et al.|Journal of the American College of Cardiology|2021Cited by 93
Cost and Value in Contemporary Heart Failure Clinical Guidance DocumentsJohn W. Ostrominski, Muthiah Vaduganathan, Sameer Hirji et al.|JACC Heart Failure|2021Cited by 18